BBVA USA Bancshares’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
BBVA USA Bancshares's IBB Position: Q1 2021 in Review
BBVA USA Bancshares increased its iShares Biotechnology ETF (IBB) stake by 30% in Q1 2021, buying an estimated $184K and bringing the position to 5,045 shares worth $759K. The position accounts for 0.04% of the portfolio, ranked #341.
BBVA USA Bancshares first reported a position in IBB in Q2 2013 and has held it in 31 quarters since. 845 funds tracked by Wall St. Rank hold IBB as of Q1 2021.
- BBVA USA Bancshares held 5,045 shares of iShares Biotechnology ETF worth $759K as of Q1 2021.
- BBVA USA Bancshares bought 1,161 iShares Biotechnology ETF shares in Q1 2021, an estimated $184K.
- iShares Biotechnology ETF made up 0.04% of BBVA USA Bancshares's portfolio in Q1 2021, its #341 holding.
- BBVA USA Bancshares first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 31 quarters since.
- 845 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2021.
Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.